WNT1 and endometrial cancer: E2 and P4 treatment of human endometrial cancer cell lines can induce the expression of miR-152, and miR-152 prevents the G1/S transition of cell cycle and inhibits cell proliferation by down-regulating the expression of WnT-1 (Wnt Family Member 1) (44).